Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX Cosmetic for Glabellar Lines Patient Satisfaction
NCT01391312Phase 4Completed
- Sponsor
- Allergan
- Start
- Jun 2011
- Primary completion
- Oct 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in glabellar lines comparing BOTOX Cosmetic with Placebo (2 arms). Primary endpoint: Percentage of Participants With Improvement in Subject Global Assessment of Change at Day 30. Started Jun 2011; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT01391312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01391312.